seen in autoimmune conditions including celiac disease, Crohn’s disease, ulcerative colitis, and psoriasis, as well as other chronic illnesses such as type II diabetes, colon cancer, and irritable bowel syndrome. It appears to be important in Crohn’s disease. Studies show that lower levels of F. prausnitzii are associated with higher rates of exacerbations in Crohn’s disease Harry Sokol et al., "Faecalibacterium prausnitzii is an Anti-Inflammatory Commensal Bacterium Identified by Gut Microbes Analysis of Crohn Disease Patients," Proceedings of the National Academy of Sciences of the United States of America 105, no. 43 (October 28, 2008): 16731-16736,